Ayala Pharmaceuticals Inc (ADXS)

[SKTrader1]

If Amgen felt they had any risk they already would’ve bought them out. I think most milestone payments are data related and later in the trials. I also believe they want to see actual data before making any kind of move. So I wouldn’t be looking at them for a lifeline.

It’s deal or dilution. The longer it goes the more ppl bet on dilution. Its really all that is left to consider here. Data too far off to save dilution.